Urokalun is a medication used for the treatment and prevention of urolithiasis and associated urinary tract conditions. It contains pipemidic acid, a quinolone derivative with antibacterial properties.

Indications for Use:

1. Urinary Tract Infections (UTIs):
   • Acute and chronic infections such as:
     • Cystitis.
     • Pyelonephritis.
     • Urethritis.
2. Prevention of Infections:
   • Prophylaxis of infections during urological interventions.

Contraindications:

• Hypersensitivity:
  • Known allergy to pipemidic acid or any components of the drug.
• Severe Renal Insufficiency:
  • Contraindicated due to altered drug excretion.
• Pregnancy and Breastfeeding:
  • Use is contraindicated.
• Pediatric Use:
  • Not recommended for individuals under 18 years of age.

Side Effects:

1. Gastrointestinal System:
   • Nausea, vomiting, diarrhea.
2. Allergic Reactions:
   • Skin rash, itching.
3. Nervous System:
   • Headache, dizziness.

Special Instructions:

1. Patients with Liver Impairment:
   • Use with caution and under medical supervision.
2. Long-Term Use:
   • Regular monitoring of renal and liver function is recommended.
3. Consultation Required:
   • Before starting Urokalun, consult a healthcare provider to assess the appropriateness of treatment and determine the optimal dosage. Self-medication may result in undesirable consequences.

 Tablets for oral administration
 - In this package: 225 mg tablets
 - Other forms of release are also possible depending on the region (granules, capsules)